[1. Turnbaugh P, Ley R, Hamady M et al. The Human Microbiome Project. Nature 2007; 449(7164): 804–810.]Search in Google Scholar
[2. Han W, Ye Y. A repository of microbial marker genes related to human health and diseases for host phenotype prediction using microbiome data. Pac Symp Biocomput 2019; 24: 236–247.]Search in Google Scholar
[3. Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver 2017; 11(2): 196–208.]Search in Google Scholar
[4. Chu H, Fox M, Zheng X et al. Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterol Res Pract 2016; 2016: 1–8.]Search in Google Scholar
[5. Di Stefano M, Quigley EMM. The diagnosis of small intestinal bacterial overgrowth: Two steps forward, one step backwards? Neurogastroenterol Motil 2018; 30(11): e13494.]Search in Google Scholar
[6. Travis J, Rutland MD, Jack A, DiPalma MD. GI/Liver Secrets 4th Edition. Saunders; 2010.]Search in Google Scholar
[7. Isaacs PE, Kim YS. Blind loop syndrome and small bowel bacterial contamination. Clin Gastroenterol 1983; 12(2): 395–414.]Search in Google Scholar
[8. Takakura W, Pimentel M. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update. Front Psychiatry 2020; 10(11): 664.]Search in Google Scholar
[9. Corazza GR, Menozzi MG, Strocchi A et al. The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology 1990; 98(2): 302–309.]Search in Google Scholar
[10. Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial over-growth: a comprehensive review. Gastroenterol Hepatol (NY) 2007; 3(2): 112–122.]Search in Google Scholar
[11. Jung KW, Seo M, Cho YH et al. Prevalence of Fructose Malabsorption in Patients With Irritable Bowel Syndrome After Excluding Small Intestinal Bacterial Overgrowth. J Neurogastroenterol Motil 2018; 24(2): 307–316.]Search in Google Scholar
[12. Bowe WP, Logan AC. Acne vulgaris, probiotics and the gut-brain-skin axis – back to the future? Gut Pathogens 2001; 3(1): 1–11.]Search in Google Scholar
[13. Salem I, Ramser A, Isham N, Ghannoum MA. The Gut Microbiome as a Major Regulator of the Gut-Skin Axis. Front Microbiol 2018; 9: 1459.]Search in Google Scholar
[14. Gajewski P, Szczeklik A. Zespół rozrostu bakteryjnego. In: Interna Szczeklika. Edition 9. Kraków: MP Wydawnictwo; 2018.]Search in Google Scholar
[15. Fialho A, Thota P, McCullough AJ, Shen B. Small Intestinal Bacterial Overgrowth Is Associated with Non-Alcoholic Fatty Liver Disease. Gastrointestin Liver Dis 2016; 25(2): 159–165.]Search in Google Scholar
[16. Siniewicz-Luzeńczyk K, Tkaczyk M. Small intestinal bacterial overgrowth syndrome in children with idiopathic nephritic syndrome treated with immunosuppressive agents. Pediatria i Medycyna Rodzinna 2016; 12(2): 171–176.]Search in Google Scholar
[17. Armbrecht U, Lundell L, Lindstedt G, Stockbruegger RW. Causes of malabsorption after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand 1988; 154(1): 37–41.]Search in Google Scholar
[18. Roland BC, Ciarleglio MM, Clarke JO, Semler JR, Tomakin E, Mullin GE, Pasricha PJ. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth. J Clin Gastroenterol 2015; 49(7): 571–576.]Search in Google Scholar
[19. Achufusi TGO, Sharma A, Zamora EA, Manocha D. Small Intestinal Bacterial Overgrowth: Comprehensive Review of Diagnosis, Prevention, and Treatment Methods. Cureus 2020; 12: e8860.]Search in Google Scholar
[20. Ahuja A, Ahuja NK. Conventional, Complementary, and Controversial Approaches to Small Intestinal Bacterial Overgrowth. Practical Gastroenterology 2018; 42(10): 60–66.]Search in Google Scholar
[21. Barboza JL, Okun MS, Moshiree B. The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease. Expert Opin Pharmacother 2015; 16(16): 2449–2464.]Search in Google Scholar
[22. Esposito S, Biscarini A, Federici B et al. Role of Small Intestinal Bacterial Overgrowth (SIBO) and Inflammation in Obese Children. Front Pediatr 2020; 8: 369.]Search in Google Scholar
[23. Miazga A, Osiński M, Cichy W et al. Current views on the etiopathogenesis, clinical manifestation, diagnostics, treatment and correlation with other nosological entities of SIBO. Adv Med Sci 2015; 60(1): 118–124.]Search in Google Scholar
[24. Walęcik-Kot W. Zespół jelita drażliwego – aktualne zasady diagnostyki i terapii. Medycyna po Dyplomie 2020 [Internet]. Available from: podyplomie.pl/medycyna/34675,zespol-jelita-drazliwego-aktualne-zasady-diagnostyki-i-terapii.]Search in Google Scholar
[25. Gasbarrini A, Corazza GR, Gasbarrini G et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther 2009; 29(1): 1–49.]Search in Google Scholar
[26. Ledochowski M, Ledochowski L. Hydrogen Breath Tests. Akadmed--Verlag Akademie für Ernahrungsmedizin GmbH Salzburg-Innsbruck, Austria 2nd edition; 2011.]Search in Google Scholar
[27. Nowak M, Gulbicka P, Grzymisławski M. Wodorowe testy oddechowe jako narzędzie w diagnostyce schorzeń gastroenterologicznych. Forum Zaburzeń Metabolicznych 2015; 6(3): 124–135.]Search in Google Scholar
[28. Rao SSC, Bhagatwala J. Small Intestinal Bacterial Overgrowth. Clinical and Translational Gastroenterology 2019; 10: e00078.]Search in Google Scholar
[29. Saad RJ, Chey WD. Breath testing for small intestinal bacterial over-growth: maximizing test accuracy. Clin Gastroenterol Hepatol 2014; 12(12): 1964–1972.]Search in Google Scholar
[30. Erdogan A, Rao SSC. Small Intestinal Fungal Overgrowth. Curr Gastroenterol Rep 2015; 17(4): 16.]Search in Google Scholar
[31. Shah SC, Day LW, Somsouk M, Sewell JL. Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth. Aliment Pharmacol Ther 2013; 38(8): 925–934.]Search in Google Scholar
[32. Magge S, Lembo A. Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y) 2012; 8(11): 739–745.]Search in Google Scholar
[33. Stolarczyk A. Składniki FODMAP w żywności. Stand Med Pediatr 2015; 12: 235–243.]Search in Google Scholar
[34. Logan AC, Venket Rao A, Irani D. Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value. Med Hypotheses 2003; 60(6): 915–923.]Search in Google Scholar
[35. Zhong C, Qu C, Wang B, Liang S, Zeng B. Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence. J Clin Gastroenterol 2017; 51(4): 300–311.]Search in Google Scholar
[36. Szymczak W, Moszak M, Bogdański P. Żywieniowe wspomaganie leczenia zespołu przerostu flory bakteryjnej jelita cienkiego – nowe koncepcje dietetyczne. Forum Zaburzeń Metabolicznych 2020; 11(1): 1–10.]Search in Google Scholar
[37. Chedid V, Dhalla S, Clarke JO et al. Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth. Glob Adv Health Med 2014; 3(3): 16–24.]Search in Google Scholar
[38. Gaffar S, Sarker S, Mahfuz M et al. Impact of Small Intestine Bacterial Overgrowth on Response to a Nutritional Intervention in Bangladeshi Children from an Urban Community. The American Journal of Tropical Medicine and Hygiene. 2019; 100(1): 222–225.]Search in Google Scholar
[39. Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol 2014; 6: 71–80.]Search in Google Scholar
| 22 set 2021